Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 4/20 | 0.69 |
| ▸ | LDHB | P07195 | 4/20 | 0.69 |
| ▸ | ALB | P02768 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7181495 | 0.81 | LDHA (1.00) | LDHALDHBALBKDM4EMAPT | |
| SCHEMBL7779298 | 0.75 | LDHA (0.53) | LDHALDHBALBNR4A2KDM4E | |
| SCHEMBL12553258 | 0.71 | NR4A2 (0.51) | LDHALDHBNR4A2KDM4ECA12 | |
| SCHEMBL2473005 | 0.71 | BCL2L1 (0.42) | LDHALDHBNR4A2KDM4ECA12 | |
| SCHEMBL8574096 | 0.70 | KDM4E (0.49) | NR4A2KDM4EGAAMAPTTDP1 | |
| SCHEMBL2761770 | 0.70 | NQO1 (0.57) | KDM4ECA12CA9MAPTHPGD | |
| SCHEMBL19202488 | 0.69 | LDHA (0.77) | LDHALDHBALBKDM4EMAPT | |
| SCHEMBL161350 | 0.69 | CA12 (0.68) | NR4A2KDM4ECA12CA1CA2 | |
| SCHEMBL23461025 | 0.69 | NR4A2 (0.53) | NR4A2CA12CA1CA2CA7 | |
| SCHEMBL27282058 | 0.69 | NR4A2 (0.53) | NR4A2KDM4ECA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | C1R, C1S, C9 | LDHA 3408/4885LDHB 2908/4885ALB 2518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.